1. Home
  2. GBIO vs EXFY Comparison

GBIO vs EXFY Comparison

Compare GBIO & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • EXFY
  • Stock Information
  • Founded
  • GBIO 2016
  • EXFY 2008
  • Country
  • GBIO United States
  • EXFY United States
  • Employees
  • GBIO N/A
  • EXFY N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • GBIO Health Care
  • EXFY Technology
  • Exchange
  • GBIO Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • GBIO 145.5M
  • EXFY 162.6M
  • IPO Year
  • GBIO 2020
  • EXFY 2021
  • Fundamental
  • Price
  • GBIO $2.44
  • EXFY $2.43
  • Analyst Decision
  • GBIO Buy
  • EXFY Hold
  • Analyst Count
  • GBIO 4
  • EXFY 6
  • Target Price
  • GBIO $7.50
  • EXFY $2.63
  • AVG Volume (30 Days)
  • GBIO 65.7K
  • EXFY 523.2K
  • Earning Date
  • GBIO 08-07-2024
  • EXFY 11-05-2024
  • Dividend Yield
  • GBIO N/A
  • EXFY N/A
  • EPS Growth
  • GBIO N/A
  • EXFY N/A
  • EPS
  • GBIO N/A
  • EXFY N/A
  • Revenue
  • GBIO $13,174,000.00
  • EXFY $138,525,000.00
  • Revenue This Year
  • GBIO $99.36
  • EXFY N/A
  • Revenue Next Year
  • GBIO N/A
  • EXFY $6.84
  • P/E Ratio
  • GBIO N/A
  • EXFY N/A
  • Revenue Growth
  • GBIO 1397.05
  • EXFY N/A
  • 52 Week Low
  • GBIO $0.86
  • EXFY $1.24
  • 52 Week High
  • GBIO $4.65
  • EXFY $4.18
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 47.29
  • EXFY 57.74
  • Support Level
  • GBIO $2.13
  • EXFY $2.21
  • Resistance Level
  • GBIO $2.49
  • EXFY $2.61
  • Average True Range (ATR)
  • GBIO 0.23
  • EXFY 0.19
  • MACD
  • GBIO -0.01
  • EXFY -0.00
  • Stochastic Oscillator
  • GBIO 38.27
  • EXFY 61.18

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.

Share on Social Networks: